Tech Company Financing Transactions

Sequoia Pharmaceuticals Funding Round

The Wellcome Trust, Aberdare Ventures and HealthCare Ventures participated in a $35 million Series C venture round for Sequoia Pharmaceuticals. The round was announced on 1/9/2007.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

401 Professional Drive 200
Gaithersburg, MD 20879
USA

Phone

(240) 632-0094

Website

www.sequoiapharma.com

Email Address

[email protected]

Overview

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases. Most anti-infective drugs were designed to block the most prevalent form of a pathogen.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steven Skolsky

        

Chief Scientific Officer

John Erickson

        

Vice President

Michael Eissenstat

        

Vice President

Sergei Gulnik

        

Vice President

Robert Guttendorf

        

Vice President

Abelardo Silva

        

Vice President

Brian Wynne

        

VP - Manufacturing

Raymond Dagger

        

Browse more venture capital transactions:

Prev: 1/9/2007: Innov-X Systems venture capital transaction
Next: 1/9/2007: LifeSync venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary